This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation. | MicrobiomeTrials
← Back to trials NCT07807423
Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation. Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-09Est. Completion: 2028-02
Enrollment target: 125 participantsLocations Clinique Rhône Durance, Avignon, France Hôpital Cardiologique Louis Pradel - HCL, Bron, France CHU Dijon, Dijon, France Hôpital Saint-Joseph Marseille, Marseille, France Clinique Rhéna, Strasbourg, France Other microbiome trials you might be interested in Atrial Fibrillation (AF)
The goal of this clinical trial is to learn if the cardiac pulsed field ablation system, composed of the cardiac pulsed …
Multiple Locations Est. completion Mar 2028
Post Cardiac Surgery Atrial Fibrillation
we compare the effect of cutting heart nerves in one group of patients with open heart surgery and other group without c…
Zagazig, Egypt Est. completion Sep 2026